Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib

Daniel J. Crona, Andrew D. Skol, Veli-Matti Leppänen, Dylan M. Glubb, Amy S. Etheridge, Eleanor Hilliard, Carol E. Pena, Yuri K. Peterson, Nancy Klauber-DeMore, Kari K. Alitalo, Federico Innocenti

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalCancer Research
Volume79
Issue number1
Pages (from-to)231-241
Number of pages11
ISSN0008-5472
DOIs
Publication statusPublished - 1 Jan 2019
MoE publication typeA1 Journal article-refereed

Fields of Science

  • FACTOR-TARGETED THERAPY
  • MULTIKINASE INHIBITOR
  • LIGAND-BINDING
  • GROWTH
  • CANCER
  • ANGIOGENESIS
  • ASSOCIATION
  • ACTIVATION
  • MECHANISMS
  • 3111 Biomedicine
  • 3122 Cancers

Cite this

Crona, Daniel J. ; Skol, Andrew D. ; Leppänen, Veli-Matti ; Glubb, Dylan M. ; Etheridge, Amy S. ; Hilliard, Eleanor ; Pena, Carol E. ; Peterson, Yuri K. ; Klauber-DeMore, Nancy ; Alitalo, Kari K. ; Innocenti, Federico. / Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib. In: Cancer Research. 2019 ; Vol. 79, No. 1. pp. 231-241.
@article{119092489b164aa89a3fd83bd1e75acb,
title = "Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib",
keywords = "FACTOR-TARGETED THERAPY, MULTIKINASE INHIBITOR, LIGAND-BINDING, GROWTH, CANCER, ANGIOGENESIS, ASSOCIATION, ACTIVATION, MECHANISMS, 3111 Biomedicine, 3122 Cancers",
author = "Crona, {Daniel J.} and Skol, {Andrew D.} and Veli-Matti Lepp{\"a}nen and Glubb, {Dylan M.} and Etheridge, {Amy S.} and Eleanor Hilliard and Pena, {Carol E.} and Peterson, {Yuri K.} and Nancy Klauber-DeMore and Alitalo, {Kari K.} and Federico Innocenti",
year = "2019",
month = "1",
day = "1",
doi = "10.1158/0008-5472.CAN-18-1089",
language = "English",
volume = "79",
pages = "231--241",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research",
number = "1",

}

Crona, DJ, Skol, AD, Leppänen, V-M, Glubb, DM, Etheridge, AS, Hilliard, E, Pena, CE, Peterson, YK, Klauber-DeMore, N, Alitalo, KK & Innocenti, F 2019, 'Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib' Cancer Research, vol. 79, no. 1, pp. 231-241. https://doi.org/10.1158/0008-5472.CAN-18-1089

Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib. / Crona, Daniel J.; Skol, Andrew D.; Leppänen, Veli-Matti; Glubb, Dylan M.; Etheridge, Amy S.; Hilliard, Eleanor; Pena, Carol E.; Peterson, Yuri K.; Klauber-DeMore, Nancy; Alitalo, Kari K.; Innocenti, Federico.

In: Cancer Research, Vol. 79, No. 1, 01.01.2019, p. 231-241.

Research output: Contribution to journalArticleScientificpeer-review

TY - JOUR

T1 - Genetic Variants of VEGFA and FLT4 Are Determinants of Survival in Renal Cell Carcinoma Patients Treated with Sorafenib

AU - Crona, Daniel J.

AU - Skol, Andrew D.

AU - Leppänen, Veli-Matti

AU - Glubb, Dylan M.

AU - Etheridge, Amy S.

AU - Hilliard, Eleanor

AU - Pena, Carol E.

AU - Peterson, Yuri K.

AU - Klauber-DeMore, Nancy

AU - Alitalo, Kari K.

AU - Innocenti, Federico

PY - 2019/1/1

Y1 - 2019/1/1

KW - FACTOR-TARGETED THERAPY

KW - MULTIKINASE INHIBITOR

KW - LIGAND-BINDING

KW - GROWTH

KW - CANCER

KW - ANGIOGENESIS

KW - ASSOCIATION

KW - ACTIVATION

KW - MECHANISMS

KW - 3111 Biomedicine

KW - 3122 Cancers

U2 - 10.1158/0008-5472.CAN-18-1089

DO - 10.1158/0008-5472.CAN-18-1089

M3 - Article

VL - 79

SP - 231

EP - 241

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 1

ER -